Lineage Cell Therapeutics
LCTX
#7537
Rank
S$0.51 B
Marketcap
S$2.25
Share price
2.66%
Change (1 day)
179.71%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Net assets

Net assets on the balance sheet as of September 2025 : S$26.97 Million

According to Lineage Cell Therapeutics 's latest financial reports the company has S$26.97 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Lineage Cell Therapeutics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$S$0.10 B27.79%
2023-12-31$S$81.91 M-15.06%
2022-12-31$S$96.43 M-21.52%
2021-12-31$S$0.12 B-2.35%
2020-12-31$S$0.12 B-16.09%
2019-12-31$S$0.14 B19.01%
2018-12-31$S$0.12 B-42.64%
2017-12-31$S$0.21 B16.32%
2016-12-31$S$0.18 B74.67%
2015-12-31$S$0.10 B30.48%
2014-12-31$S$82.87 M54.78%
2013-12-31$S$53.54 M80.23%
2012-12-31$S$29.7 M-44.67%
2011-12-31$S$53.69 M-15.67%
2010-12-31$S$63.66 M310.51%
2009-12-31$S$15.5 M-349.48%
2008-12-31$-S$6.22 Million41.8%
2007-12-31$-S$4.39 Million53.27%
2006-12-31$-S$2.87 Million773.84%
2005-12-31$-S$0.33 Million-158.19%
2004-12-31$S$0.56 M-113.62%
2003-12-31$-S$4.13 Million103.21%
2002-12-31$-S$2.04 Million1007.76%
2001-12-31$-S$0.19 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
ORIC Pharmaceuticals
ORIC
S$0.52 B 1,856.72%๐Ÿ‡บ๐Ÿ‡ธ USA